Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 31, Issue 2, 2012, Pages 335-339

  Wang, Chao ^a   Chen, Li Li ^a   Pan, Hai Feng ^a   Leng, Rui Xue ^a   Qin, Wei Zi ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Systemic lupus erythematosus; TWEAK

Indexed keywords

APOPTOSIS INDUCING FACTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS GENE; VASCULITIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR NECROSIS FACTORS;

EID: 84856706706     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1865-4     Document Type: Article

References (18)

1. JA Winkles 2008 The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat Rev Drug Discov 7 5 411 425 18404150 10.1038/nrd2488 1:CAS:528:DC%2BD1cXlt1agtb0%3D (Pubitemid 351619113)
2. Y Chicheportiche PR Bourdon H Xu, et al. 1997 TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis J Biol Chem 272 51 32401 32410 9405449 10.1074/jbc.272.51.32401 1:CAS:528: DyaK1cXis1Ojug%3D%3D (Pubitemid 28011923)
3. SR Wiley JA Winkles 2003 TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor Cytokine Growth Factor Rev 14 3-4 241 249 12787562 10.1016/S1359-6101(03)00019-4 1:CAS:528:DC%2BD3sXkt1Ghsrk%3D (Pubitemid 36693144)
4. S Campbell J Michaelson L Burkly, et al. 2004 The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity Front Biosci 9 2273 2284 15353286 10.2741/1395 1:CAS:528:DC%2BD2cXltl2nurs%3D
5. RL Meighan-Mantha DK Hsu Y Guo, et al. 1999 The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration J Biol Chem 274 46 33166 33176 10551889 10.1074/jbc.274.46.33166 1:CAS:528:DyaK1MXntlynsrk%3D (Pubitemid 129535361)
6. SL Feng Y Guo VM Factor, et al. 2000 The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas Am J Pathol 156 4 1253 1261 10751351 10.1016/S0002-9440(10)64996-6 1:CAS:528:DC%2BD3cXjtV2isbc%3D (Pubitemid 30660004)
7. J Inoue T Ishida N Tsukamoto, et al. 2000 Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling Exp Cell Res 254 1 14 24 10623461 10.1006/excr.1999.4733 1:CAS:528:DC%2BD3cXht1Chtg%3D%3D (Pubitemid 30066727)
8. A Ortiz AB Sanz B Muñoz García, et al. 2009 Considering TWEAK as a target for therapy in renal and vascular injury Cytokine Growth Factor Rev 20 3 251 258 19482507 10.1016/j.cytogfr.2009.05.002 1:CAS:528:DC%2BD1MXnsFaitLk%3D
9. M Yepes 2007 TWEAK and the central nervous system Mol Neurobiol 35 3 255 265 17917114 10.1007/s12035-007-0024-z 1:CAS:528:DC%2BD2sXht1aisbvP (Pubitemid 350129687)
10. M Yepes 2007 Tweak and FN14 in central nervous system health and disease Front Biosci 12 2772 2781 17485258 10.2741/2271 1:CAS:528:DC%2BD2sXms1Kmsrw%3D
11. Leng RX, Pan HF, Qin WZ, Wang C, Chen LL et al (2010) TWEAK as a target for therapy in systemic lupus erythematosus. Mol Biol Rep. doi: 10.1007/s11033-010-0144-9
12. N Schwartz L Su LC Burkly, et al. 2006 Urinary TWEAK and the activity of lupus nephritis J Autoimmun 27 4 242 250 17257812 10.1016/j.jaut.2006.12.003 1:CAS:528:DC%2BD2sXhs1ChtLY%3D (Pubitemid 46206104)
13. A Manoharan MP Madaio 2010 Biomarkers in lupus nephritis Rheum Dis Clin North Am 36 1 131 143 20202595 10.1016/j.rdc.2009.12.009
14. Y Chicheportiche L Fossati-Jimack S Moll, et al. 2000 Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies Biochem Biophys Res Commun 279 1 162 165 11112433 10.1006/bbrc.2000.3913 1:CAS:528:DC%2BD3cXosFGgtL0%3D
15. Z Zhao LC Burkly S Campbell, et al. 2007 TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus J Immunol 179 11 7949 7958 18025243 1:CAS:528:DC%2BD2sXhtlajt7bI
16. TS Zheng LC Burkly 2008 No end in site: TWEAK/Fn14 activation and autoimmunity-associated end-organ pathologies J Leukoc Biol 84 2 338 347 18483204 10.1189/jlb.0308165 1:CAS:528:DC%2BD1cXptF2htrw%3D
17. SS ElGendi WT El-Sherif 2009 Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement Egypt J Immunol 16 1 135 148 20726330
18. N Schwartz T Rubinstein LC Burkly, et al. 2009 Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study Arthritis Res Ther 11 5 R143 19785730 10.1186/ar2816